- Home
- MORN vs MRNA Comparison
MORN vs MRNA Comparison
Compare MORN & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MORN
- MRNA
- Stock Information
- Founded
- MORN 1984
- MRNA 2010
- Country
- MORN United States
- MRNA United States
- Employees
- MORN N/A
- MRNA N/A
- Industry
- MORN Investment Managers
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MORN Finance
- MRNA Health Care
- Exchange
- MORN Nasdaq
- MRNA Nasdaq
- Market Cap
- MORN 9.0B
- MRNA 9.2B
- IPO Year
- MORN 2005
- MRNA 2018
- Fundamental
- Price
- MORN $215.17
- MRNA $26.40
- Analyst Decision
- MORN Strong Buy
- MRNA Hold
- Analyst Count
- MORN 3
- MRNA 15
- Target Price
- MORN $333.33
- MRNA $36.69
- AVG Volume (30 Days)
- MORN 400.6K
- MRNA 12.0M
- Earning Date
- MORN 10-29-2025
- MRNA 11-06-2025
- Dividend Yield
- MORN 0.85%
- MRNA N/A
- EPS Growth
- MORN 16.18
- MRNA N/A
- EPS
- MORN 8.80
- MRNA N/A
- Revenue
- MORN $2,395,400,000.00
- MRNA $2,232,000,000.00
- Revenue This Year
- MORN $8.52
- MRNA N/A
- Revenue Next Year
- MORN $7.45
- MRNA $10.38
- P/E Ratio
- MORN $24.39
- MRNA N/A
- Revenue Growth
- MORN 7.76
- MRNA N/A
- 52 Week Low
- MORN $202.89
- MRNA $23.04
- 52 Week High
- MORN $365.00
- MRNA $48.92
- Technical
- Relative Strength Index (RSI)
- MORN 43.79
- MRNA 51.87
- Support Level
- MORN $206.68
- MRNA $23.04
- Resistance Level
- MORN $217.21
- MRNA $25.56
- Average True Range (ATR)
- MORN 5.58
- MRNA 1.56
- MACD
- MORN 1.16
- MRNA 0.02
- Stochastic Oscillator
- MORN 65.56
- MRNA 52.44
About MORN Morningstar Inc.
Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.